Hot News
| The Hearing for the Investigation concerning Anadolu Kılavuzluk Anonim Şirketi, Deniz Kılavuzluk Anonim Şirketi, Marin Römorkör ve Kılavuzluk Anonim Şirketi, Sanmar Denizcilik Makina ve Ticaret Anonim Şirketi to be held on September 22, 2026 | 11.9.2026 | ||
| The investigation conducted to determine whether the undertakings operating in marine pilotage and towage services sector violated the Act No. 4054 on the Protection of Competition by means of bid rigging in application and tender processes related to pilotage and towage services and exchanging competitively sensitive information in labor markets has reached the hearing stage. The hearing will be held on September 22, 2026 at 10:30. In accordance with the "Communiqué on Hearings Held bef... | |||
| Read | |||
| Investigation has been initiated about 37 undertakings and two associations of undertakings suspected of being party to competition infringements regarding the labor market. | 7.9.2026 | ||
| The Competition Board (the Board) concluded the preliminary inquiry conducted about the claim that TOSB Automotive Supply Specialized Organized Industrial Zone and its members violated article 4 of the Act No. 4054 on the Protection of Competition (the Act No. 4054) by means of no-poach agreements regarding the labor sector and/or exchanging competitively sensitive information. As a result of the examinations made, it was considered that sufficient suspicion rose that the undertakings operati... | |||
| Read | |||
| A WORKSHOP WILL BE HELD WITHIN THE SCOPE OF THE PHARMACEUTICAL SECTOR INQUIRY. (21.09.2026) | 31.8.2026 | ||
| The Preliminary Report prepared as part of the Pharmaceutical Sector Inquiry conducted by the Turkish Competition Authority with a view to assessing, from a holistic perspective, the competition concerns arising across the pharmaceutical sector’s value chain, extending from research and development and manufacturing to licensing, reimbursement, distribution, and the delivery of medicines to patients, was published on 10 August 2026. Under the inquiry, the competitive structure of the pharmace... | |||
| Read | |||
| Acquisition of sole control over Warner Bros. Discovery Inc. By Paramount Skydance Corporation authorized, subject to conditions | 29.8.2026 | ||
| With the decision dated 20.08.2026 and numbered 26-30/866-361, the Competition Board (Board) granted conditional authorization to the transaction involving the acquisition of sole control over Warner Bros. Discovery Inc. (WARNER BROS) by Paramount Skydance Corporation (PARAMOUNT), subject to the commitments submitted by PARAMOUNT. The file identified certain instances of horizontal and vertical overlap between the activities of PARAMOUNT and WARNER BROS. The file assessed the commitments offe... | |||
| Read | |||
| Investigation Launched on Undertakings Operating in the Plant Protection or Plant Nutrition Products Market | 28.8.2026 | ||
| In accordance with the Competition Board Decision dated 06.08.2026 and numbered 26-28/802-M, an investigation has been launched on undertakings operating in the plant protection or plant nutrition products market, including Adama Turkey Tarım Sanayi ve Ticaret Ltd Şti., Agrobest Grup Tarım İlaçları Tohumculuk İmalat İthalat İhracat Sanayi ve Ticaret AŞ, Agrofarm Kimya Sanayi ve Ticaret AŞ, AMC-TR Tarım Sanayi ve Ticaret AŞ, Astranova Tarım Ticaret ve Sanayi AŞ, BASF Agricultural Solutions Turkey... | |||
| Read | |||
| Investigation Launched on TEVA. | 21.8.2026 | ||
| The Competition Board (Board) concluded the preliminary inquiry conducted in order to determine if Teva İlaçları San. ve Tic. AŞ (TEVA) violated Article 6 of the Act no 4054 on the Protection of Competition (Act no 4054) by engaging in conduct intended to restrict competition from generic medicines, through the strategic use of divisional patent procedures and creation of a misleading impression before healthcare authorities regarding the efficacy and safety of competing products. The Board l... | |||
| Read | |||
| Pharmaceutical Sector Inquiry Preliminary Report Published | 10.8.2026 | ||
| According to the Competition Board decision dated 08.12.2021 and numbered 21-59/844-M, a sector inquiry was initiated to detect the structural competition problems in the pharmaceutical sector and offer competitive solutions. The pharmaceutical sector, due to its structural characteristics and features that are different from other sectors, is among the sectors that competition authorities prioritize both in Türkiye and around the world. Therefore, proactive identification and assessment of t... | |||
| Read | |||
| The acquisition of CARREFOURSA by A101 conditionally authorized | 6.8.2026 | ||
| The Competition Board (the Board) has conditionally authorized the acquisition by Yeni Mağazacılık AŞ (A101) of the sole control of Carrefoursa Carrefour Sabancı Ticaret Merkezi AŞ (CARREFOURSA) with the decision dated 30.07.2026 and numbered 26-27/789-331 within the framework of the commitment package submitted by A101 including both behavioral and structural commitments. The decision determines that the transaction is an acquisition subject to authorization according to article 7 of the Ac... | |||
| Read | |||
| Investigation Conducted on the economic unity composed of Avixa İlaç San. ve Tic. AŞ and Avigem İlaç San. ve Tic. Ltd. Şti. concluded through the commitment and settlement procedures. | 4.8.2026 | ||
| The investigation which evaluated the conduct of the economic unity composed of Avixa İlaç San. ve Tic. AŞ and Avigem İlaç San. ve Tic. Ltd. Şti. (AVIXA) involving its refusal to offer to the market one of the two nasal sprays that it distributed under the scope of the co-marketing agreement, thereby preventing the entry of competitors into the double action nasal spray market and causing public losses, with respect to Article 6 of the Act no 4054 on the Protection of Competition has been conclu... | |||
| Read | |||
| Investigation Launched on Undertakings Operating in the Nuclear Medicine Market | 28.7.2026 | ||
| According to the Competition Board decision dated 30.04.2026 and numbered 26-16/481-M, an investigation has been launched on Medicheck Nükleer Ürünler San. ve Tic. AŞ, Referans Nükleer Tıp Sağlık Ltd. Şti., Fefa Nükleer Tıp Ticaret Ltd. Şti., Sintias Moleküler Sağlık Ürünleri San. ve Tic. AŞ, Sintias Nükleer Tıp Tic. Ltd. Şti., Nukleon Nükleer Teknoloji Araştırma San. ve Tic. Ltd. Şti., Bianco Sağlık Ürünleri Ticaret Pazarlama Ltd. Şti., Nukleus Sağlık Hizmetleri AŞ, MNT Sağlık Hizmetleri ve Tic... | |||
| Read | |||